We are live on
!
Find out more
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
ARMO
Delisted
ARMO was delisted on the 21st of June, 2018.
0 hedge funds and large institutions have $0 invested in ARMO BioSciences, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 65 → 0 (-65)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $509M → $0 (-$509M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 63
Holders
–
Holders Change
-65
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
63
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$154M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$45.4M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$45.2M |
| 4 |
BlackRock
New York
|
-$30.8M |
| 5 |
HH
HSG Holding
Na,
Hong Kong
|
-$30.3M |
